Tag - Myomo

Myomo Receives Accreditation from HQAA

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that the Healthcare Quality Association on Accreditation (HQAA) has certified Myomo meets the accreditation requirements under the Social Security Act and federal regulations. Read more >>

Myomo Provides Update on CMS Discussions

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today provided an update regarding its application for a Healthcare Common Procedure Coding System (“HCPCS”) Level II code change and benefit category redetermination for HCPCS codes L8701 and L8702 submitted in January 2021. Read more >>

Myomo to Present at the Summer Solstice – Best Ideas From the Buy Side Conference

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that CEO Paul R. Gudonis and CFO David Henry will present at the Summer Solstice – Best Ideas From the Buy Side Conference on June 1, 2021 at 2:30 p.m. Eastern time. The conference is sponsored by the Microcap Rodeo and will be held virtually June 1-4, 2021. Read more >>

Myomo to Present at the Winter Wonderland – Best Ideas from the Buy-side Conference

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that management will present at the Winter Wonderland – Best Ideas from the Buy-side Conference. The conference is being held virtually on February 16th through February 19th. Read more >>

Myomo Reports Preliminary Fourth Quarter and Full Year 2020 Results

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced preliminary financial and operational results for the fourth quarter and fiscal year ended December 31, 2020. In particular, Myomo expects revenue for the three months ended December 31, 2020 to more than double compared with the fourth quarter ended December 31, 2019, and also expects quarterly cash utilization to be the lowest since it became a publicly […]

Myomo to Present H.C. Wainwright Virtual BioConnect 2021 Conference

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, the Company’s chief executive officer, and David Henry, chief financial officer, will present at the H.C. Wainwright Virtual BioConnect 2021 Conference being held January 11-14, 2021. Read more >>

Myomo Introduces MyoGames – Video Games Played via MyoPro for Training, Rehabilitation and Fun

Myomo, Inc., a wearable medical robotics company offering increased functionality for individuals suffering from neurological disorders and upper-limb paralysis, announced today the availability of MyoGames by Lusio, a video game platform designed to augment training and rehabilitation for MyoPro users, while being fun. Read more >>

Myomo names chief medical officer

Myomo today said it appointed Dr. Harry Kovelman as chief medical officer, effective immediately. Kovelman will be responsible for overseeing the company’s patient advocacy organization. He will work with commercial and government payer organizations to increase patient access to the MyoPro product line. Read more >>